CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prasad, G. L.
Right arrow Articles by Cooper, H. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prasad, G. L.
Right arrow Articles by Cooper, H. L.

Cell Growth & Differentiation, Vol 3, Issue 8 507-513, Copyright © 1992 by American Association of Cancer Research


ARTICLES

Complementary DNA cloning of a novel epithelial cell marker protein, HME1, that may be down-regulated in neoplastic mammary cells

GL Prasad, EM Valverius, E McDuffie and HL Cooper
Cell and Molecular Physiology Section, National Cancer Institute, Bethesda, Maryland 20892.

A full-length complementary DNA clone from a normal human mammary epithelial cell (strain 184) encoding a 25-kilodalton protein, HME1, was isolated. Expression of HME1 RNA appears to be limited to epithelial cells. The HME1 sequence has extensive sequence homology with bovine 14-3-3 protein, which is an activator of tyrosine and tryptophan hydroxylase. However, the tissue distribution, arrangement of charged amino acids, and location of potential phosphorylation sites of HME1 differ from those of 14-3-3. Compared with normal mammary epithelial cells, expression of HME1 RNA was dramatically low in two cell lines derived from human mammary carcinoma that were examined, and in a line of normal mammary epithelial cells transformed by oncogenes. HME1 therefore appears to be a cellular differentiation marker that may be down-regulated during neoplastic transformation.


This article has been cited by other articles:


Home page
J Biol ChemHome page
K. Raychaudhuri, N. Chaudhary, M. Gurjar, R. D'Souza, J. Limzerwala, S. Maddika, and S. N. Dalal
14-3-3{sigma} Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun Protein
J. Biol. Chem., July 29, 2016; 291(31): 16068 - 16081.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Boudreau, K. Tanner, D. Wang, F. C. Geyer, J. S. Reis-Filho, and M. J. Bissell
14-3-3{sigma} stabilizes a complex of soluble actin and intermediate filament to enable breast tumor invasion
PNAS, October 8, 2013; 110(41): E3937 - E3944.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
Z. Aktary, S. Kulak, J. Mackey, N. Jahroudi, and M. Pasdar
Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3{sigma}
J. Cell Sci., July 15, 2013; 126(14): 3031 - 3042.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
T. Murata, K.-i. Takayama, T. Urano, T. Fujimura, D. Ashikari, D. Obinata, K. Horie-Inoue, S. Takahashi, Y. Ouchi, Y. Homma, et al.
14-3-3{zeta}, a Novel Androgen-Responsive Gene, Is Upregulated in Prostate Cancer and Promotes Prostate Cancer Cell Proliferation and Survival
Clin. Cancer Res., October 15, 2012; 18(20): 5617 - 5627.
[Abstract] [Full Text] [PDF]


Home page
Cancer DiscoveryHome page
C. Ling, V.-M.-T. Su, D. Zuo, and W. J. Muller
Loss of the 14-3-3{sigma} Tumor Suppressor Is a Critical Event in ErbB2-Mediated Tumor Progression
Cancer Discovery, January 1, 2012; 2(1): 68 - 81.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. M. Sureban, R. May, S. A. Lightfoot, A. B. Hoskins, M. Lerner, D. J. Brackett, R. G. Postier, R. Ramanujam, A. Mohammed, C. V. Rao, et al.
DCAMKL-1 Regulates Epithelial-Mesenchymal Transition in Human Pancreatic Cells through a miR-200a-Dependent Mechanism
Cancer Res., March 15, 2011; 71(6): 2328 - 2338.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C.-H. Su, R. Zhao, F. Zhang, C. Qu, B. Chen, Y.-H. Feng, L. Phan, J. Chen, H. Wang, H. Wang, et al.
14-3-3{sigma} Exerts Tumor-Suppressor Activity Mediated by Regulation of COP1 Stability
Cancer Res., February 1, 2011; 71(3): 884 - 894.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Du, C. Zhang, S. Hassan, M. H. U. Biswas, and K. C. Balaji
Protein Kinase D1 Suppresses Epithelial-to-Mesenchymal Transition through Phosphorylation of Snail
Cancer Res., October 15, 2010; 70(20): 7810 - 7819.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A.-L. Cheng, W.-G. Huang, Z.-C. Chen, F. Peng, P.-F. Zhang, M.-Y. Li, F. Li, J.-L. Li, C. Li, H. Yi, et al.
Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis
Clin. Cancer Res., January 15, 2008; 14(2): 435 - 445.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
N. J. Godde, G. M. D'Abaco, L. Paradiso, and U. Novak
Efficient ADAM22 surface expression is mediated by phosphorylation-dependent interaction with 14-3-3 protein family members
J. Cell Sci., August 15, 2006; 119(16): 3296 - 3305.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
B. Han, H. Xie, Q. Chen, and J.-T. Zhang
Sensitizing hormone-refractory prostate cancer cells to drug treatment by targeting 14-3-3{sigma}.
Mol. Cancer Ther., April 1, 2006; 5(4): 903 - 912.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Yang, Y.-Y. Wen, R. Zhao, Y.-L. Lin, K. Fournier, H.-Y. Yang, Y. Qiu, J. Diaz, C. Laronga, and M.-H. Lee
DNA Damage-Induced Protein 14-3-3 {sigma} Inhibits Protein Kinase B/Akt Activation and Suppresses Akt-Activated Cancer
Cancer Res., March 15, 2006; 66(6): 3096 - 3105.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Liu, H. Liu, B. Han, and J.-T. Zhang
Identification of 14-3-3{sigma} as a Contributor to Drug Resistance in Human Breast Cancer Cells Using Functional Proteomic Analysis
Cancer Res., March 15, 2006; 66(6): 3248 - 3255.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
H. Yang, R. Zhao, and M.-H. Lee
14-3-3{sigma}, a p53 regulator, suppresses tumor growth of nasopharyngeal carcinoma.
Mol. Cancer Ther., February 1, 2006; 5(2): 253 - 260.
[Abstract] [Full Text] [PDF]


Home page
MCPHome page
J. M. A. Moreira, G. Ohlsson, F. E. Rank, and J. E. Celis
Down-regulation of the Tumor Suppressor Protein 14-3-3{sigma} Is a Sporadic Event in Cancer of the Breast
Mol. Cell. Proteomics, April 1, 2005; 4(4): 555 - 569.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. Cheng, C.-X. Pan, J.-T. Zhang, S. Zhang, M. S. Kinch, L. Li, L. A. Baldridge, C. Wade, Z. Hu, M. O. Koch, et al.
Loss of 14-3-3{sigma} in Prostate Cancer and Its Precursors
Clin. Cancer Res., May 1, 2004; 10(9): 3064 - 3068.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. K. Dougherty and D. K. Morrison
Unlocking the code of 14-3-3
J. Cell Sci., April 15, 2004; 117(10): 1875 - 1884.
[Abstract] [Full Text] [PDF]


Home page
MCPHome page
J. M. A. Moreira, P. Gromov, and J. E. Celis
Expression of the Tumor Suppressor Protein 14-3-3{sigma} Is Down-regulated in Invasive Transitional Cell Carcinomas of the Urinary Bladder Undergoing Epithelial-to-Mesenchymal Transition
Mol. Cell. Proteomics, April 1, 2004; 3(4): 410 - 419.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
H.-Y. Yang, Y.-Y. Wen, C.-H. Chen, G. Lozano, and M.-H. Lee
14-3-3{sigma} Positively Regulates p53 and Suppresses Tumor Growth
Mol. Cell. Biol., October 15, 2003; 23(20): 7096 - 7107.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. D. Braastad, Z. Han, and E. A. Hendrickson
Constitutive DNase I Hypersensitivity of p53-Regulated Promoters
J. Biol. Chem., March 7, 2003; 278(10): 8261 - 8268.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Bhatia, A. K Siraj, A. Hussain, R. Bu, and M. I Gutierrez
The Tumor Suppressor Gene 14-3-3{sigma} Is Commonly Methylated in Normal and Malignant Lymphoid Cells
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 165 - 169.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. Megyesi, L. Andrade, J. M. Vieira Jr., R. L. Safirstein, and P. M. Price
Coordination of the cell cycle is an important determinant of the syndrome of acute renal failure
Am J Physiol Renal Physiol, October 1, 2002; 283(4): F810 - F816.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Gasco, A. K. Bell, V. Heath, A. Sullivan, P. Smith, L. Hiller, I. Yulug, G. Numico, M. Merlano, P. J. Farrell, et al.
Epigenetic Inactivation of 14-3-3 {sigma} in Oral Carcinoma: Association with p16INK4a Silencing and Human Papillomavirus Negativity
Cancer Res., April 1, 2002; 62(7): 2072 - 2076.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
T. Samuel, H. O. Weber, P. Rauch, B. Verdoodt, J.-T. Eppel, A. McShea, H. Hermeking, and J. O. Funk
The G2/M Regulator 14-3-3{varsigma} Prevents Apoptosis through Sequestration of Bax
J. Biol. Chem., November 30, 2001; 276(48): 45201 - 45206.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R. Yoshikawa, M. Kusunoki, H. Yanagi, M. Noda, J.-i. Furuyama, T. Yamamura, and T. Hashimoto-Tamaoki
Dual Antitumor Effects of 5-Fluorouracil on the Cell Cycle in Colorectal Carcinoma Cells: A Novel Target Mechanism Concept for Pharmacokinetic Modulating Chemotherapy
Cancer Res., February 1, 2001; 61(3): 1029 - 1037.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A.-S. Vercoutter-Edouart, J. Lemoine, X. Le Bourhis, H. Louis, B. Boilly, V. Nurcombe, F. Revillion, J.-P. Peyrat, and H. Hondermarck
Proteomic Analysis Reveals that 14-3-3{{sigma}} Is Down-Regulated in Human Breast Cancer Cells
Cancer Res., January 1, 2001; 61(1): 76 - 80.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Dhar, J. A. Squire, M. P. Hande, R. J. Wellinger, and T. K. Pandita
Inactivation of 14-3-3sigma Influences Telomere Behavior and Ionizing Radiation-Induced Chromosomal Instability
Mol. Cell. Biol., October 15, 2000; 20(20): 7764 - 7772.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. Laronga, H.-Y. Yang, C. Neal, and M.-H. Lee
Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression
J. Biol. Chem., July 28, 2000; 275(30): 23106 - 23112.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. T. Ferguson, E. Evron, C. B. Umbricht, T. K. Pandita, T. A. Chan, H. Hermeking, J. R. Marks, A. R. Lambers, P. A. Futreal, M. R. Stampfer, et al.
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer
PNAS, May 23, 2000; 97(11): 6049 - 6054.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. M. Passalaris, J. A. Benanti, L. Gewin, T. Kiyono, and D. A. Galloway
The G2 Checkpoint Is Maintained by Redundant Pathways
Mol. Cell. Biol., September 1, 1999; 19(9): 5872 - 5881.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D. Pallas, H Fu, L. Haehnel, W Weller, R. Collier, and T. Roberts
Association of polyomavirus middle tumor antigen with 14-3-3 proteins
Science, July 22, 1994; 265(5171): 535 - 537.
[Abstract] [PDF]


Home page
J Biol ChemHome page
T. Samuel, H. O. Weber, P. Rauch, B. Verdoodt, J.-T. Eppel, A. McShea, H. Hermeking, and J. O. Funk
The G2/M Regulator 14-3-3{varsigma} Prevents Apoptosis through Sequestration of Bax
J. Biol. Chem., November 30, 2001; 276(48): 45201 - 45206.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
C. Laronga, H.-Y. Yang, C. Neal, and M.-H. Lee
Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression
J. Biol. Chem., July 28, 2000; 275(30): 23106 - 23112.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. T. Ferguson, E. Evron, C. B. Umbricht, T. K. Pandita, T. A. Chan, H. Hermeking, J. R. Marks, A. R. Lambers, P. A. Futreal, M. R. Stampfer, et al.
High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer
PNAS, May 23, 2000; 97(11): 6049 - 6054.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1992 by the American Association of Cancer Research.